Pipradrol conditioned place preference is blocked by SCH23390

Norman M. White, Noboru Hiroi

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

We investigated the effect of the selective D1 dopamine antagonist, SCH23390, on the establishment of a pipradrol-conditioned place preference (CPP). Among various doses of pipradrol (6.25-75.0 mg/kg, SC), a CPP was established at 25.0 mg/kg. SCH23390 (0.16 mg/kg, IP) blocked establishment of a CPP by this dose of pipradrol. The results suggest that pipradrol produces a rewarding effect and that this effect may involve activation of D1dopamine receptors.

Original languageEnglish (US)
Pages (from-to)377-380
Number of pages4
JournalPharmacology, Biochemistry and Behavior
Volume43
Issue number2
DOIs
StatePublished - 1992
Externally publishedYes

Fingerprint

Dopamine Antagonists
Chemical activation
SCH 23390
pipradrol

Keywords

  • Affect
  • Conditioned place preference
  • Conditioned reward
  • D
  • Dopamine
  • Motivation
  • Reinforcement
  • Reward
  • SCH23390

ASJC Scopus subject areas

  • Biochemistry
  • Behavioral Neuroscience
  • Pharmacology

Cite this

Pipradrol conditioned place preference is blocked by SCH23390. / White, Norman M.; Hiroi, Noboru.

In: Pharmacology, Biochemistry and Behavior, Vol. 43, No. 2, 1992, p. 377-380.

Research output: Contribution to journalArticle

White, Norman M. ; Hiroi, Noboru. / Pipradrol conditioned place preference is blocked by SCH23390. In: Pharmacology, Biochemistry and Behavior. 1992 ; Vol. 43, No. 2. pp. 377-380.
@article{0b3d43f178d446258d102d19c3baba9b,
title = "Pipradrol conditioned place preference is blocked by SCH23390",
abstract = "We investigated the effect of the selective D1 dopamine antagonist, SCH23390, on the establishment of a pipradrol-conditioned place preference (CPP). Among various doses of pipradrol (6.25-75.0 mg/kg, SC), a CPP was established at 25.0 mg/kg. SCH23390 (0.16 mg/kg, IP) blocked establishment of a CPP by this dose of pipradrol. The results suggest that pipradrol produces a rewarding effect and that this effect may involve activation of D1dopamine receptors.",
keywords = "Affect, Conditioned place preference, Conditioned reward, D, Dopamine, Motivation, Reinforcement, Reward, SCH23390",
author = "White, {Norman M.} and Noboru Hiroi",
year = "1992",
doi = "10.1016/0091-3057(92)90165-C",
language = "English (US)",
volume = "43",
pages = "377--380",
journal = "Pharmacology Biochemistry and Behavior",
issn = "0091-3057",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Pipradrol conditioned place preference is blocked by SCH23390

AU - White, Norman M.

AU - Hiroi, Noboru

PY - 1992

Y1 - 1992

N2 - We investigated the effect of the selective D1 dopamine antagonist, SCH23390, on the establishment of a pipradrol-conditioned place preference (CPP). Among various doses of pipradrol (6.25-75.0 mg/kg, SC), a CPP was established at 25.0 mg/kg. SCH23390 (0.16 mg/kg, IP) blocked establishment of a CPP by this dose of pipradrol. The results suggest that pipradrol produces a rewarding effect and that this effect may involve activation of D1dopamine receptors.

AB - We investigated the effect of the selective D1 dopamine antagonist, SCH23390, on the establishment of a pipradrol-conditioned place preference (CPP). Among various doses of pipradrol (6.25-75.0 mg/kg, SC), a CPP was established at 25.0 mg/kg. SCH23390 (0.16 mg/kg, IP) blocked establishment of a CPP by this dose of pipradrol. The results suggest that pipradrol produces a rewarding effect and that this effect may involve activation of D1dopamine receptors.

KW - Affect

KW - Conditioned place preference

KW - Conditioned reward

KW - D

KW - Dopamine

KW - Motivation

KW - Reinforcement

KW - Reward

KW - SCH23390

UR - http://www.scopus.com/inward/record.url?scp=0026483515&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026483515&partnerID=8YFLogxK

U2 - 10.1016/0091-3057(92)90165-C

DO - 10.1016/0091-3057(92)90165-C

M3 - Article

C2 - 1359572

AN - SCOPUS:0026483515

VL - 43

SP - 377

EP - 380

JO - Pharmacology Biochemistry and Behavior

JF - Pharmacology Biochemistry and Behavior

SN - 0091-3057

IS - 2

ER -